SmartCells
Insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.
Employees
Enterprise value
$500m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
$500m Valuation: $500m | Acquisition | ||
| Total Funding | 000k | ||
Converge Venture Partners(exited)
Angel Healthcare Investors(exited)
Boston Harbor Angels(exited)
Cherrystone Angels(exited)
Beacon Angels(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads